It was suggested that TGF-β3 with a physiological concentration as low as 0.1 ng/mL, which was comparable to the physiological AH concentration in the AH of XFG patients, can exert significant effects on fibrotic changes in HTM cells, although the effects were stronger with higher concentrations. This evidence concerns the gene TGFB3 and exfoliation syndrome.